Synthesis of Novel Compounds as New Potent Tyrosinase Inhibitors

Hamidian, Hooshang

doi:https://doi.org/10.1155/2013/207181

BioMed Research International

On this page

Abstract Introduction Results and Discussion Experimental Conclusion References Copyright Related Articles

Research Article | Open Access

Volume 2013 | Article ID 207181 | https://doi.org/10.1155/2013/207181

Synthesis of Novel Compounds as New Potent Tyrosinase Inhibitors

Hooshang Hamidian¹

Academic Editor: Hirotaka Iwase

Received01 Jul 2013

Accepted05 Sept 2013

Published22 Oct 2013

Abstract

In the present paper, we report the synthesis and pharmacological evaluation of a new series of azo compounds with different groups (1-naphthol, 2-naphthol, and N,N-dimethylaniline) and trifluoromethoxy and fluoro substituents in the scaffold. All synthesized compounds (5a–5f) showed the most potent mushroom tyrosinase inhibition (IC₅₀ values in the range of 4.39 ± 0.76–1.71 ± 0.49 µM), comparable to the kojic acid, as reference standard inhibitor. All the novel compounds were characterized by FT-IR, ¹H NMR, ¹³C NMR, and elemental analysis.

1. Introduction

Tyrosinase inhibitors are clinically useful for the treatment of skin diseases associated with melanin hyperpigmentation and applied in cosmetics for whitening and depigmentation after sunburn. Melanin is a heteropolymer of indole compounds and is produced inside melanosomes by the action of the tyrosinase enzyme on the tyrosinase precursor material in melanocytes. It has recently been discovered that some other factors such as metal ions and the TRP-1 and TRP-2 enzymes also contribute to the production of melanin. However, tyrosinase plays a critical role in the regulation of melanin biosynthesis. Therefore, many tyrosinase inhibitors that suppress melanogenesis have been widely studied with the aim of developing preparations for the treatment of hyperpigmentation [1–5].

It is well known that azo compounds are the most widely used class of industrial synthesized organic compounds because of their versatile usage in different fields, like dyeing textile fiber, biological–pharmacological activities, and advanced usage in organic synthesis [6–13]. In recent years, the fabrication of azo dyes has been widely investigated because of their unique industrial usages in hypnotic drugs, in living cells, in detecting cancer and owning pharmacological and biological activities [14–17].

In this research, we synthesized number of new azo compounds and studied chemical structures. Also we evaluated inhibitory effect on tyrosinase, melanin production inhibition and cytotoxicity of new compounds.

2. Results and Discussion

Diazonium salts could react readily with nucleophiles as aromatic compounds containing amino or hydroxyl group, which have been widely researched and applied for the preparation of molecules with importance for both academic and industrial applications. The solution of 4-amino hippuric acid and sodium nitrite in a 2.5% sodium carbonate was diazotized by slow addition of conc. HCl at 0°C. A yellow precipitate diazonium salt (2) was formed. The coupling components (N,N-dimethylaniline, 1-naphthol, and 2-naphthol) were added to diazonium salt of 4-aminohippuric acid. Azo compounds 3a–3c were produced in good yields. Diazonium salt was coupled with the para-position of the amine group, 2-position of hydroxyl group in 1-naphthol and 1-position of hydroxyl group in 2-naphthol. Then, 4-arylidene-5(4H)-oxazolones 4a–4f were synthesized by classical Erlenmeyer reaction, involving condensation of compounds 3a–3c with 4-fluorobenzaldehyde and 4-trifluoromethoxy benzaldehyde in the presence of acetic anhydride and sodium acetate under refluxing conditions. New azo compounds 5a–5f were prepared by the reaction of 4-arylidene-5(4H)-oxazolones 4a–4f and 3,4-dithio-toluene in the presence of triethylamine at the room temperature in dry benzene (Scheme 1).

Generally, variation in color of these dyes results from the alternation in the coupling components, since the synthesized dyes which were obtained varied in color from red to brown. Compounds (5a–5f) were stable solids whose structures were established by FT-IR, ¹H NMR, ¹³C NMR spectroscopy, and elemental analysis (Table 1).

The compounds 5a–5f demonstrated excellent in vitro tyrosinase inhibitory properties having IC₅₀ values in the range of 4.39 ± 0.76–1.71 ± 0.49 μM, whereas standard inhibitor, Kojic acid has IC₅₀ value 16.67 ± 0.52 μM (Table 2 and Figure 1).

Also inhibitions of the compounds 5a–5f were tested on melanin production and their cytotoxicity on B16F10 mouse melanoma cells at concentrations of 20 μg/mL. The results of melanin production inhibition and cytotoxicity by the compounds 5a–5f are showed in Table 3.

Compounds 5e and 5f having IC₅₀ values and , respectively, were found to be very active members of the series, even better than standard inhibitor. 1-(2-{4-[({1-{[(4-Methyl-3-sulfanylphenyl)sulfanyl] carbonyl}-2-[4-(trifluoromethoxy)phenyl]-1-ethenyl}amino) carbonyl]phenyl}-1-diazenyl)-2-naphthyl acetate 5f was found to be the most active one having IC₅₀ = μM among all tested compounds.

Comparing the activities with the structures of compounds, it turns out that the tyrosinase activity is mainly dependent on the substituent present at C-4 positions of aryl ring (-F or −CF₃). When tyrosinase inhibitory activity of the most active compounds 5b, 5d, and 5f was compared with other compounds 5a, 5c, and 5e, it was observed that it has a 4-(trifluoromethoxy) phenyl group on the aliphatic double bond.

A decrease in the activity of compounds 5a and 5b as compared to compounds 5c–5f was due to the change in the phenyl to naphthyl at azo group. This shows that extension of conjugation through an aliphatic double bond could be the prerequisite for activity rather than extension through an aromatic ring.

The least activity of compound 5a (IC₅₀ μM) may be due to changing the substituent in phenyl rings present at C-4 and aromatic ring. Compound 5f (IC₅₀ μM) was found to be highly active member of the present series of azo compounds. Its excellent activity may be due to the presence of naphthyl ring and the presence of a trifluoromethoxy group in phenyl ring at C-4, which meets the criteria for achieving extension of conjugation. Compound 5e (IC₅₀ μM) is structurally similar to compound 5f except where trifluoromethoxy group is replaced by fluoro. Interestingly, compounds 5a–5d having IC₅₀ values , , , and μM, respectively, showed good activity.

Compounds 5a–5f prevented melanin production by 42.15%, 40.98%, 35.93%, 37.50%, 36.84%, and 34.74%, respectively, at concentrations of 20 μg/mL. On the other hand, compounds 5a–5f have shown moderate inhibition of melanin production. Cytotoxicity of new compounds 5a–5f was evaluated and was defined that all compounds were less toxic (Table 3).

All synthesized azo dyes exhibited high tyrosinase inhibitory behavior. The results of mushroom tyrosinase inhibition assays indicate that the 4-trifluoromethoxy derivatives have high degrees of inhibition and 1-naphthol and 2-naphthol derivatives are better for tyrosinase inhibition than N,N-dimethylaniline derivatives. All synthesized azo compounds 5a–5f showed the most potent mushroom tyrosinase inhibition, comparable to that of Kojic acid as reference standard inhibitors.

3. Experimental

3.1. General Information

All the chemicals were obtained from Merck, Fluka, and Sigma-Aldrich and were used without further purification. Melting points were measured using Thermo Fisher Scientific. IR spectra were recorded by Bruker tensor 27, FT- IR spectrophotometer. All ¹H NMR and ¹³C NMR spectra were recorded by a Bruker 400 MHz spectrophotometer. Chemical shifts are reported in parts per million (ppm) using tetramethylsilane (TMS) as an internal standard. The mass spectra were run on a Shimadzu Qp 5050 Ex spectrometer. The microanalyses for C, H, and N were performed on Perkin-Elmer elemental analyzer. Ultraviolet-visible (UV-vis) absorption spectra were recorded on a Perkin Elmer spectrophotometer at the wavelength of maximum absorption () in dimethylsulphoxide (DMSO) at the same level of concentration (1 × 10⁻⁵M).

3.2. Preparation of Diazonium Salt of 4-Aminohippuric Acid (2)

In a 125-mL erlenmeyer flask, 4-aminohippuric acid (0.01 mol) was added to 2% sodium carbonate solution (30 mL) until it was dissolved by boiling. The solution were then cooled down and sodium nitrite (0.01 mol) was added, with stirring, until it was dissolved. The solution was cooled down by placing in an ice bath, and then it was acidified by hydrochloric acid (2 mL), and then water (3 mL) was added. By acidifying the solution, a powdery yellow precipitate of the diazonium salt was separated.

3.3. Sodium 2-[4-{2-[4-(dimethylamino)phenyl]-1-diazenyl} benzoylamino] Acetate (3a)

N,N-Dimethylaniline (0.01 mol) and glacial acetic acid (0.01 mol) were mixed. The solution of N,N-dimethylaniline acetate was added to suspension of hippuric acid, diazonium salt with stirring and acid-stable form of the dye was separated. A stiff paste was formed in 5–10 min and then sodium hydroxide (5 g) was added. The product was collected using saturated sodium chloride solution. The crude product was crystallized from water. Orange powder, decomposed >270°C yield is 81%. IR (KBr): , 1716 cm⁻¹. ¹H NMR (400 MHZ, DMSO-D₆): 3.07 (s, 6H, 2CH₃), 3.61 (d, 2H, Hz, CH2), 6.84 (d, 2H, Hz, ArH), 7.80–7.82 (m, 4H, ArH), 7.92 (broad, 1H, NH), 7.98 (d, 2H, , ArH) ppm. C₁₇H₁₇O₃N₄Na (348) calcd. C 58.65, H 4.88, N 16.08; found. C 58.54, H 4.92, N 16.18.

3.4. Sodium 2-({4-[2-(1-hydroxy-2-naphthyl)-1-diazenyl]benzoyl}amino) Acetate (3b)

2-Naphthol (0.01 mol) was dissolved in 5% sodium hydroxide solution (30 mL). The solution of 2-naphthol was added to suspension of hippuric acid diazonium salt with stirring, and base-stable form of the dye was separated. A stiff paste was formed in 5–10 min and then 10 mL of 10% acetic acid was added. The product was collected using saturated sodium chloride solution. The crude product was crystallized from water. The crude product was crystallized from water. Red powder, decomposed >236°C yield is 81%. IR (KBr): , 3364, 1714 cm⁻¹. ¹H NMR (400 MHz, DMSO-D₆): 3.61 (d, 2H, Hz, CH2), 6.88–8.63 (m, 12H, ArH, NH, OH) ppm. C₁₉H₁₄N₃O₄Na (371) calcd. C 61.46, H 3.77, N 11.32; found. C 61.73, H 3.66, N 11.09.

3.5. Sodium 2-({4-[2-(2-hydroxy-1-naphthyl)-1-diazenyl]benzoyl}amino) Acetate (3c)

1-Naphthol (0.01 mol) was dissolved in 5% sodium hydroxide solution (30 mL). The solution of 2-naphthol was added to suspension of hippuric acid diazonium salt with stirring and base-stable form of the dye was separated. A stiff paste was formed in 5–10 min, and then 10 mL of 10% acetic was added. The product was collected using saturated sodium chloride solution. The crude product was crystallized from water. Red powder, decomposed >259°C yield is 81%. IR (KBr): , 3355, 1710 cm⁻¹. ¹H NMR (400 MHz, DMSO-D₆): 3.64 (d, 2H, Hz, CH2), 6.90–8.89 (m, 12H, ArH, NH, OH) ppm,. C₁₉H₁₄N₃O₄Na (371) calcd. C 61.46, H 3.77, N 11.32; found. C 61.25, H 4.02, N 11.18.

3.6. General Procedure for Synthesis of Compounds 4a–4f

A mixture of anhydrous sodium acetate (0.01 mol), 4-fluoro benzaldehyde or 4-trifluoromethoxy benzaldehyde (0.01 mol), sodium salt of azo dye 3a–3c (0.01 mol), and acetic anhydride (40 mL) was heated with stirring until the mixture was transformed from an orange semisolid mass to a deep red liquid for 2–4 h. After cooling, the precipitated product was filtered and recrystallized in toluene [18].

3.7. General Procedure for Synthesis of Compounds 5a–5f

To a solution of compounds 4a–4f (2 mmol) in 50 mL of dry benzene was added 0.312 g (2 mmol) of 3,4-dithio-toluene and 0.2 mL of triethylamine. The mixture was stirred for 3 h at room temperature, then filtered, and washed with dry benzene. The residue was recrystallized from ethanol 96%.

3.8. Spectroscopic Data

3.8.1. 4-Methyl-2-sulfanylphenyl(E)-2-[(4-{(E)-2-[4-(dimethylamino)phenyl]-1-diazenyl}benzoyl)amino]-3-(4-fluorophenyl)-2-propenethioate (5a)

Red powder; m.p. 293°C (decomposed); IR (KBr) : 3279 (NH), 1722 (C=O), 1662 (C=O) cm⁻¹. ¹H NMR (DMSO-D₆, 400 MHz) : 2.23 (s, 3H, CH₃), 3.14 (s, 6H, 2CH₃), 4.35 (broad, 2H, NH and SH), 6.76–8.29 (m, 16H, vinyl and aromatic); ¹³C NMR (ppm): 21.1, 41.3, 112.7, 114.4, 123,9, 125.6, 126.5, 127.3, 127.6, 127.9, 129.1, 129.5, 129.8, 132.0, 134.7, 136.8, 138.0, 148.6, 152.4, 155.7, 156.1, 156.4, 171.4, 181.9; Anal. Calcd for C₃₁H₂₇N₄O₂FS₂: C, 65.26; H, 4.74; N, 9.82. Found: C, 65.01; H, 4.53; N, 9.63.

3.8.2. 4-Methyl-2-sulfanylphenyl(E)-2-[(4-{(E)-2-[4-(dimethylamino)phenyl]-1-diazenyl}benzoyl)amino]-3-[4-(trifluoromethoxy)phenyl]-2-propenethioate (5b)

Brown powder; m.p. 286°C (decomposed); IR (KBr) : 3352 (NH), 1716 (C=O), 1641 (C=O) cm⁻¹. ¹H NMR (DMSO-D₆, 400 MHz) : 2.38 (s, 3H, CH₃), 3.16 (s, 6H, 2CH₃), 4.24 (broad, 2H, NH and SH), 6.77–8.37 (m, 16H, vinyl and aromatic). ¹³C NMR (ppm): 21.1, 41.3, 113.9, 115.7, 118.3, 123.7, 125.9, 126.2, 126.5, 127.3, 129.1, 129.4, 130.1, 131.9, 134.2, 134.7, 135.2, 138.1, 148.4, 150.2, 152.4, 155.6, 156.3, 171.2, 181.5; Anal. Calcd for C₃₂H₂₇N₄O₃F₃S₂: C, 63.58; H, 4.47; N, 9.27. Found: C, 63.22; H, 4.09; N, 8.97.

3.8.3. 2-[(E)-2-(4-{[((E)-2-(4-fluorophenyl)-1-{[(4-methyl-2-sulfanylphenyl) sulfanyl] carbonyl}-1-ethenyl) amino]carbonyl}phenyl)-1-diazenyl]-1-naphthyl Acetate (5c)

Brown powder; m.p. 308°C (decomposed); IR (KBr) : 3241 (NH), 1765 (C=O), 1666 (C=O) cm⁻¹. ¹H NMR (DMSO-D₆, 400 MHz) : 2.24 (s, 3H, CH₃), 2.53 (s, 3H, CH₃), 3.15 (broad, 2H, NH and SH), 7.29–8.77 (m, 17H, vinyl and aromatic); ¹³C NMR (ppm): 22.5, 41.2, 115.4, 118.1, 118.9, 124.1, 125.0, 125.5, 125.7, 126.1, 127.1, 127.5, 128.3, 129.0, 129.9, 130.4, 130.6, 131.8, 132.1, 132.9, 133.9, 135.2, 137.5, 138.9, 145.1, 151.7, 154,4, 157.1, 165.1, 170.9, 180.3; Anal. Calcd for C₃₅H₂₆N₃O₄FS₂: C, 66.14; H, 4.09; N, 6.61. Found: C, 65.86; H, 4.33; N, 6.38.

3.8.4. 2-((E)-2-{4-[({(E)-1-{[(4-Methyl-2-sulfanylphenyl) sulfanyl] carbonyl}-2-[4-(trifluoromethoxy)phenyl]-1-ethenyl}amino)carbonyl]phenyl}-1-diazenyl)-1-naphthyl Acetate (5d)

Red powder; m.p. 318°C (decomposed); IR (KBr) : 3281 (NH), 1741 (C=O), 1666 (C=O) cm⁻¹. ¹H NMR (DMSO-D₆, 400 MHz) : 2.37 (s, 3H, CH₃), 2.53 (s, 3H, CH₃), 3.36 (s, 1H, SH), 7.27–9.02 (m, 19H, vinyl and aromatic, NH); ¹³C NMR (ppm): 22.5, 41.2, 114.9, 117.1, 118.3, 123.7, 125.1, 125.7, 126.2, 127.1, 127.4, 127.9, 128.5, 129.1, 129.8, 130.4, 130.9, 131.9, 132.2, 132.7, 134.1, 134.7, 136.1, 137.3, 138.4, 146.6, 148.1, 152.4, 155.9, 165.6, 170.8, 180.5; Anal. Calcd for C₃₆H₂₆N₃O₅F₃S₂: C, 61.63; H, 3.71; N, 5.99. Found: C, 61.44; H, 3.47; N, 6.07.

3.8.5. 1-[(E)-2-(4-{[((E)-2-(4-fluorophenyl)-1-{[(4-methyl-2-sulfanylphenyl)sulfanyl] carbonyl}-1-ethenyl) amino]carbonyl}phenyl)-1-diazenyl]-2-naphthyl Acetate (5e)

Red powder; m.p. 325°C (decomposed); IR (KBr) : 3304 (NH), 1741 (C=O), 1666 (C=O) cm⁻¹. ¹H NMR (DMSO-D₆, 400 MHz) : 2.20 (s, 3H, CH₃), 2.65 (s, 3H, CH₃), 3.34 (s, 1H, SH), 7.27–9.14 (m, 19H, vinyl and aromatic, NH); ¹³C NMR (ppm): 21.4, 41.3, 113.4, 117.1, 118.3, 123.4, 125.0, 125.5, 125.9, 126.1, 127.3, 127.5, 128.2, 129.0, 129.4, 130.4, 130.6, 131.9, 132.4, 132.8, 134.2, 135.2, 137.3, 138.1, 144.3, 152.3, 155.8, 156.3, 167.6, 171.5, 181.4; Anal. Calcd for C₃₅H₂₆N₃O₄FS₂: C, 66.14; H, 4.09; N, 6.61. Found: C, 65.98; H, 4.45; N, 6.39.

3.8.6. 1-((E)-2-{4-[({(E)-1-{[(4-Methyl-2-sulfanylphenyl) sulfanyl] carbonyl}-2-[4-(trifluoromethoxy)phenyl]-1-ethenyl}amino)carbonyl]phenyl}-1-diazenyl)-2-naphthyl Acetate (5f)

Red powder; m.p. 320°C (decomposed); IR (KBr) : 3308 (NH), 1721 (C=O), 1665 (C=O) cm⁻¹. ¹H NMR (DMSO-D₆, 400 MHz) : 2.12 (s, 3H, CH₃), 2.54 (s, 3H, CH₃), 3.34 (s, 1H, SH), 7.24–9.01 (m, 19H, vinyl and aromatic, NH); ¹³C NMR (ppm): 21.4, 41.2, 115.7, 117.3, 118.3, 123.7, 125.4, 125.9, 126.2, 127.1, 127.3, 127.5, 128.0, 129.1, 129.4, 130.1, 130.3, 131.9, 132.2, 132.8, 134.1, 134.7, 135.2, 137.3, 138.1, 144.1, 148.4, 152.4, 156.3, 167.6, 171.2, 181.5; Anal. Calcd for C₃₆H₂₆N₃O₅F₃S₂: C, 61.63; H, 3.71; N, 5.99. Found: C, 61.92; H, 4.03; N, 6.11.

3.9. Tyrosinase Inhibition Assay

The spectrophotometric assay for tyrosinase was performed according to the method Ref 15. Briefly, all the synthesized compounds were screened for the diphenolase inhibitory activity of tyrosinase using L-DOPA as substrate. All the compounds were dissolved in DMSO. The final concentration of DMSO in the test solution was 2.0%. Phosphate buffer, pH=6.8, was used to dilute the DMSO stock solution of test compounds. Thirty units of mushroom tyrosinase (0.5 mg/mL) were first preincubated with the compounds, in 50 mM phosphate buffer (pH 6.8), for 10 min at 25°C. Then the L-DOPA (0.5 mM) was added to the reaction mixture, and the enzyme reaction was monitored by measuring the change in absorbance at 475 nm of formation of the L-DOPA chrome for 10 min. The measurement was performed in triplicate for each concentration and averaged before further calculation. IC₅₀ value, a concentration giving 50% inhibition of tyrosinase activity, was determined by interpolation of the dose-response curves. The percent of inhibition of tyrosinase reaction was calculated as the following: Here, the and are the absorbances for the blank and samples. All the experiments were carried out at least in triplicate, and the results represent means ± SEM (standard error of the mean). Kojic acid was used as reference standard inhibitors for comparison.

3.10. Inhibition of Melanin Production

Melanin production inhibition was ascertained by method of Wang et al. [19]. A total of 8 × 10⁴ cells were added to 60 mm plates and were incubated at 37°C in a CO₂ incubator, then, 10 μL test samples in DMSO were added to plates and were incubated for 72 hours at 37°C in a CO₂ incubator. After washing with PBS, cells were destroyed with 1 mL of 1 N NaOH, and 200 μL portions of raw cell extracts were moved to 96-well plates. Melanin production inhibition was determined by recording absorbance at 495 nm. The effects of test samples on melanin contents are stated as percent inhibitions of the value obtained in B16F10 mouse melanoma cells which were cultured with DMSO alone.

3.11. Cytotoxicity Assay

Cytotoxicity assays were performed using a microculture MTT method described by Han et al. [20]. A B16F10 mouse melanoma cell suspension was poured into a 96-well plate (10³ cells/well), and cells were allowed to completely stick to each other overnight. Test samples were then added to the plate and were incubated at 37°C for 72 h in a CO₂ incubator. 20 μL of MTT solution (2 mg/mL) was then added per well and incubated for 4 hours. Supernatant was then removed, and formazan was solubilized by adding 150 μL DMSO to each well with mild shaking. Absorbance at 490 nm was recorded using an ELISA plate reader.

4. Conclusion

All synthesized azo dyes exhibited high tyrosinase inhibitory behavior. The results of mushroom tyrosinase inhibition assays indicate that the 4-trifluoromethoxy derivatives have high degrees of inhibition and 1-naphthol and 2-naphthol derivatives are better for tyrosinase inhibition than N,N-dimethylaniline derivatives. All synthesized azo compounds 5a–5f showed the most potent mushroom tyrosinase inhibition, comparable to that of Kojic acid as reference standard inhibitors.

Acknowledgment

This work was supported by the Payame Noor University (PNU).

References

H.-S. Lee, “Tyrosinase inhibitors of Pulsatilla cernua root-derived materials,” Journal of Agricultural and Food Chemistry, vol. 50, no. 6, pp. 1400–1403, 2002.
View at: Publisher Site | Google Scholar
Y. Masamoto, H. Ando, Y. Murata, Y. Shimoishi, M. Tada, and K. Takahata, “Mushroom tyrosinase inhibitory activity of esculetin isolated from seeds of Euphorbia lathyris L,” Bioscience, Biotechnology and Biochemistry, vol. 67, no. 3, pp. 631–634, 2003.
View at: Google Scholar
P. B. Bandgar, L. K. Adsul, H. V. Chavan et al., “Synthesis, biological evaluation, and molecular docking of N- ${$ 3-[3-(9-methyl-9H-carbazol-3-yl)-acryloyl]-phenyl $}$ -benzamide/amide derivatives as xanthine oxidase and tyrosinase inhibitors,” Bioorganic and Medicinal Chemistry, vol. 20, no. 18, pp. 5649–5657, 2012.
View at: Google Scholar
J. C. Cho, H. S. Rho, Y. H. Joo et al., “Depigmenting activities of kojic acid derivatives without tyrosinase inhibitory activities,” Bioorganic and Medicinal Chemistry Letters, vol. 22, no. 12, pp. 4159–4162, 2012.
View at: Google Scholar
U. Ghani and N. Ullah, “New potent inhibitors of tyrosinase: novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones, and substituted hydrazides to the dicopper active site,” Bioorganic and Medicinal Chemistry, vol. 18, no. 11, pp. 4042–4048, 2010.
View at: Publisher Site | Google Scholar
I. M. A. Awad, A. H. Osman, and A. A. M. Aly, “Heterocyclo-substituted sulfa drugs: part XII. Mercapto-S-azo-benzothiazol dyes and their metal complexes,” Phosphorus, Sulfur and Silicon and the Related Elements, vol. 178, no. 6, pp. 1339–1352, 2003.
View at: Publisher Site | Google Scholar
B. Akkurt and E. Hamuryudan, “Enhancement of solubility via esterification: synthesis and characterization of octakis (ester)-substituted phthalocyanines,” Dyes and Pigments, vol. 79, no. 2, pp. 153–158, 2008.
View at: Publisher Site | Google Scholar
A. M. Sevim, S. Arkan, A. Koca, and A. Gül, “Synthesis and spectroelectrochemistry of new phthalocyanines with ester functionalities,” Dyes and Pigments, vol. 92, no. 3, pp. 1114–1121, 2012.
View at: Publisher Site | Google Scholar
H. Khanmohammadi and M. Darvishpour, “New azo ligands containing azomethine groups in the pyridazine-based chain: aynthesis and characterization,” Dyes and Pigments, vol. 81, no. 3, pp. 167–173, 2009.
View at: Publisher Site | Google Scholar
A. Z. Al-Rubaie, A. A. Al-Fregi, and S. A. S. Al-Jadaan, “Synthesis of a new series of 2-(2-hydroxynaphthylazo)aryltellurium compounds,” Phosphorus, Sulfur and Silicon and the Related Elements, vol. 186, no. 1, pp. 115–124, 2011.
View at: Publisher Site | Google Scholar
M. M. M. Raposo, A. M. R. C. Sousa, A. M. C. Fonseca, and G. Kirsch, “Thienylpyrrole azo dyes: synthesis, solvatochromic and electrochemical properties,” Tetrahedron, vol. 61, no. 34, pp. 8249–8256, 2005.
View at: Publisher Site | Google Scholar
F. Karci, A. Demirçali, I. Şener, and T. Tilki, “Synthesis of 4-amino-1H-benzo[4,5]imidazo[1,2-H]pyrimidin-2-one and its disperse azo dyes. Part 1: phenylazo derivatives,” Dyes and Pigments, vol. 71, no. 2, pp. 90–96, 2006.
View at: Publisher Site | Google Scholar
M. R. Yazdanbakhsh, A. Ghanadzadeh, and E. Moradi, “Synthesis of some new azo dyes derived from 4-hydroxy coumarin and spectrometric determination of their acidic dissociation constants,” Journal of Molecular Liquids, vol. 136, no. 1-2, pp. 165–168, 2007.
View at: Publisher Site | Google Scholar
H. Zeng, Z. P. Lin, and A. C. Sartorelli, “Resistance to purine and pyrimidine nucleoside and nucleobase analogs by the human MDR1 transfected murine leukemia cell line L1210/VMDRC.06,” Biochemical Pharmacology, vol. 68, no. 5, pp. 911–921, 2004.
View at: Publisher Site | Google Scholar
P. Sharma, N. Rane, and V. K. Gurram, “Synthesis and QSAR studies of pyrimido[4,5-d]pyrimidine-2,5-dione derivatives as potential antimicrobial agents,” Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 16, pp. 4185–4190, 2004.
View at: Publisher Site | Google Scholar
C. Q. Huang, K. M. Wilcoxen, D. E. Grigoriadis, J. R. McCarthy, and C. Chen, “Design and synthesis of 3-(2-pyridyl)pyrazolo[1,5-a]pyrimidines as potent CRF1 receptor antagonists,” Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 15, pp. 3943–3947, 2004.
View at: Publisher Site | Google Scholar
M. F. Abdel-Megeed, B. E. Badr, M. M. Azaam, and G. A. El-Hiti, “Antimicrobial activities of a series of diphenyl(arylamino)(1-phenyl-3-(pyridin-2-Yl)-1H-pyrazol-4-Yl)methylphosphonates phosphorus,” Phosphorus, Sulfur, and Silicon and the Related Elements, vol. 187, no. 10, pp. 1202–1207, 2012.
View at: Google Scholar
H. Hamidian, R. Tagizadeh, S. Fozooni, V. Abbasalipour, A. Taheri, and M. Namjou, “Synthesis of novel azo compounds containing 5(4H)-oxazolone ring as potent tyrosinase inhibitors,” Bioorganic and Medicinal Chemistry, vol. 21, no. 7, pp. 2088–2092, 2013.
View at: Google Scholar
H.-M. Wang, C.-Y. Chen, C.-Y. Chen et al., “(-)-N-Formylanonaine from Michelia alba as a human tyrosinase inhibitor and antioxidant,” Bioorganic and Medicinal Chemistry, vol. 18, no. 14, pp. 5241–5247, 2010.
View at: Publisher Site | Google Scholar
J. Han, I. Ma, M. J. Hendzel, and J. Allalunis-Turner, “The cytotoxicity of γ-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by γ-secretase inhibition,” Breast Cancer Research, vol. 11, no. 4, article R57, 2009.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2013 Hooshang Hamidian. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

2151

Downloads

1743

Citations